Efficacy of differential non-invasive approaches in determining the clinical course in patients with Crohn’s disease

Balasubramanian, Lakshman Kumar; Kuppanan, Suresh; Vellingiri, Balachandar; Keshavrao, Sasikala; Leelakrishnan, Venkatakrishnan

Efficacy of differential non-invasive approaches in determining the clinical course in patients with Crohn’s disease

Volume 5 (2011): Issue 5 (October 2011)

By:

Lakshman Kumar Balasubramanian, Suresh Kuppanan, Balachandar Vellingiri, Sasikala Keshavrao and Venkatakrishnan Leelakrishnan

Open Access

|Feb 2017

References

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002; 347:417-29.10.1056/NEJMra020831
Search in Google Scholar Back to article
2. Ahmad T, Tamboli CP, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterol. 2004; 126: 1533-49.10.1053/j.gastro.2004.01.061
Open DOI Search in Google Scholar Back to article
3. Venkatakrishnan L, Thakaran A, Francis J, Ramesh GN, Philip M, Augustine P. Crohn’s disease-analysis of 26 cases. Indian J Gastroenterol. 1995; 14:A58.
Search in Google Scholar Back to article
4. Pai CG, Khandige GK. Is Crohn’s disease rare in India? Indian J Gastroenterol. 2000; 19:17-20.
Search in Google Scholar Back to article
5. Amarapurkar D, Patel N. Crohn’s disease in India. Gastroenterol Today. 2002; 6:73-5.
Search in Google Scholar Back to article
6. Tan CC, Kang JY, Guan R. Inflammatory bowel disease: an uncommon problem in Singapore. J Gastroenterol Hepatol. 1992, 7:360-2.10.1111/j.1440-1746.1992.tb00997.x
Open DOI Search in Google Scholar Back to article
7. Thien-Htut Kudva MV. Ulcerative colitis in Malaysians: a review of 23 patients. Singapore Med. 1989; 30:385-7.
Search in Google Scholar Back to article
8. Lai CL, Wu PC, Wong KL, et al. Clinical features of ulcerative proctocolitis in Hong Kong Chinese: a review of three decades. Am J Proctol Gastroenterol Colon Rectal Surg. 1985; 1:14-9.
Search in Google Scholar Back to article
9. Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol. 2005; 21:408-13.
Search in Google Scholar Back to article
10. Loftus EV. Clinical epidemiology of inflammatory bowel disease.Gastroenterology. 2004; 126:1504-17.10.1053/j.gastro.2004.01.063
Open DOI Search in Google Scholar Back to article
11. Makharia GK. Rising incidence and prevalence of Crohn’s disease in Asia: is it apparent or real?. J Gastroenterol Hepatol. 2006; 21:1009-15.10.1111/j.1440-1746.2006.04471.x
Open DOI Search in Google Scholar Back to article
12. Jiang XL, Cui HF. An analysis of 10 218 ulcerative colitis cases in China. World J Gastroenterol. 2002; 8:158-61.10.3748/wjg.v8.i1.158
Search in Google Scholar Back to article
13. Jiang L, Xia B, Li J, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis. 2006; 12:212-7.10.1097/01.MIB.0000201098.26450.ae
Open DOI Search in Google Scholar Back to article
14. Yang SK, Hong WS, Min YI, et al. Incidence and prevalence of ulcerative colitis in the SongpaKangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol. 2000; 15:1037-42.10.1046/j.1440-1746.2000.02252.x
Open DOI Search in Google Scholar Back to article
15. Lee YM, Fock KM, See SJ, et al: Racial differences in the prevalenceof ulcerative colitis and Crohn’s disease in Singapore. J Gastroenterol Hepatol. 2000; 15:622-5.10.1046/j.1440-1746.2000.02212.x
Open DOI Search in Google Scholar Back to article
16. Makharia GK, Tandon RK. Emergence of Celiac Disease and Crohn’s Disease in India. Medicine Update. 2008;. 18:250-6.
Search in Google Scholar Back to article
17. Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology. 1975; 68:627-35.10.1016/S0016-5085(75)80270-8
Search in Google Scholar Back to article
18. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: Useful, magic, or unnecessary toys?. Gut. 2006; 55:426-31.10.1136/gut.2005.069476
Open DOI Search in Google Scholar Back to article
19. Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus EV Jr, Harmsen WS, et al. Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut. 2006; 55:1561-7.10.1136/gut.2005.084301
Open DOI Search in Google Scholar Back to article
20. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut. 2006; 55:426-31.10.1136/gut.2005.069476
Open DOI Search in Google Scholar Back to article
21. Fagan EA, Dyck RF, Maton PN, Hodgson HJ, Chadwick VS, Petrie A, et al. Serum levels of C-reactive protein in Crohn’s disease and ulcerative colitis. Eur J Clin Invest. 1982; 12:351-9.10.1111/j.1365-2362.1982.tb02244.x
Open DOI Search in Google Scholar Back to article
22. Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for infl ammatory bowel disease. Inflamm Bowel Dis. 2004; 10:661-5.10.1097/00054725-200409000-00026
Open DOI Search in Google Scholar Back to article
23. Boirivant M, Leoni M, Tariciotti D, Fais S, Squarcia O, Pallone F. The clinical signifi cance of serum C reactive protein levels in Crohn’s disease. Results of a prospective longitudinal study. J Clin Gastroenterol. 1988; 10:401-5.10.1097/00004836-198808000-00011
Open DOI Search in Google Scholar Back to article
24. Shine B, Berghouse L, Jones JE, Landon J. Creactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta. 1985; 148:105-9.10.1016/0009-8981(85)90219-0
Open DOI Search in Google Scholar Back to article
25. Filik L, Dagli U, Ulker A. C-reactive protein and monitoring the activity of Crohn’s disease. Adv Ther. 2006; 23:655-62.10.1007/BF0285005417050508
Open DOI Search in Google Scholar Back to article
26. Koelewijn CL, Schwartz MP, Samsom M, Oldenburg B. C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease. World J Gastroenterol. 2008; 14:85-9.10.3748/wjg.14.85267339718176967
Open DOI Search in Google Scholar Back to article
27. Florin TH, Paterson EW, Fowler EV, Radford-Smith GL. Clinically active Crohn’s disease in the presence of a low C-reactive protein. Scand J Gastroenterol. 2006; 41:306-11.10.1080/0036552050021711816497618
Open DOI Search in Google Scholar Back to article
28. Cavanaugh J. NOD2: Ethnic and geographic differences. World J Gastroenterol. 2006; 12:3673-7.10.3748/wjg.v12.i23.3673
Open DOI Search in Google Scholar Back to article
29. Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn’s disease in India where tuberculosis is widely prevalent. World J Gastroenterol. 2008; 14: 741-6.10.3748/wjg.14.741
Open DOI Search in Google Scholar Back to article
30. Balachandar V, Lakshman Kumar B, Sasikala K, Manikantan P, Sangeetha R, Mohana Devi S. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients. J Zhejiang Univ Sci. 2007; B 8: 638-46.10.1631/jzus.2007.B0638
Open DOI Search in Google Scholar Back to article
31. Mendoza J.L, Murillo L.S, Fernandez L, Pena A.S, Lana R, Urcelay E, et al. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn’s disease. Scand J Gastroenterol. 2003; 38:1235-40.10.1080/00365520310006612
Open DOI Search in Google Scholar Back to article
32. Cavanaugh JA, Adams KE, Quak EJ, Bryce ME, O’Callaghan NJ, Rodgers HJ, et al. CARD15/NOD2 risk alleles in the development of Crohn’s disease in the Australian population. Ann Hum Genet. 2003; 67: 35-41.10.1046/j.1469-1809.2003.00006.x
Open DOI Search in Google Scholar Back to article
33. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterol. 1976; 70:439-44.10.1016/S0016-5085(76)80163-1
Search in Google Scholar Back to article
34. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn’s disease. Gastroenterol. 2002; 123:86-91.10.1053/gast.2002.3415512105836
Open DOI Search in Google Scholar Back to article
35. Lee Y.J, Han Y, Lu H.T, Nguyen V, Qin H, Howe P.H, Hocevar B.A, Boss J.M, Ransohoff R.M, Benveniste E.N (1997). TGF-beta suppresses IFN-gamma induction of class II MHC geneexpression by inhibiting class II transactivator messenger RNA expression. J Immunol. 1997; 158:2065-75.
Search in Google Scholar Back to article
36. Sandborn WJ, Colombel JF, Enns R, et al. Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group. Natalizumab induction and maintenance therapy for Crohn’s disease. N Engl J Med. 2005; 353: 1912-25.10.1056/NEJMoa04333516267322
Search in Google Scholar Back to article
37. Schreiber S, Rutgeerts P, Fedorak RN, et al. A randomized, placebo controlled trial of certolizumab pegol (CDP870) for treatment of Crohn’s disease. Gastroenterology. 2005; 129:807-18.10.1053/j.gastro.2005.06.06416143120
Open DOI Search in Google Scholar Back to article
38. Kaur P, Sambyal V. Lymphocytic chromosomal instability in sporadic gastrointestinal tract cancer patients and their first-degree relatives. Int J Hum Genet. 2008; 8:335-42.10.1080/09723757.2008.11886049
Search in Google Scholar Back to article
39. Chen Y, Tzengb C, Lioub C, Changb M, Lib C, Linb C. Biological significance of chromosomal imbalance aberrations in gastrointestinal stromal tumors. J Biomed Sci. 2004; 11:65-71.10.1007/BF02256550
Open DOI Search in Google Scholar Back to article
40. Rossner P, Boffetta P, Capp M, Bonassi S, Smerhovsky Z, Landa K, et al. Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Hlth Persp 2005; 113:517-20.10.1289/ehp.6925
Open DOI Search in Google Scholar Back to article
41. El-Zein R, Gu Y, Sierra MS, Spitz MR, Strom SS. Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14:748-52.10.1158/1055-9965.EPI-04-0236
Open DOI Search in Google Scholar Back to article
42. Boffetta P, Vander Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, et al. Chromosomal aberrations and cancer risk. Results of a cohort study from central Europe. Am J Epidemio. 2007; 165:36-43.10.1093/aje/kwj367
Open DOI Search in Google Scholar Back to article
43. Ghosh P, Banerjee M, Chaudhari S, Das JK, Sarma N, Basu A,Giri AK. Increased chromosome aberration frequencies in Bowen’s patients compared to noncancerous skin lesions in individuals exposed to arsenic. Mutat Res. 2007; 632:104-10.10.1016/j.mrgentox.2007.05.005
Search in Google Scholar Back to article
44. Barletta C, Scillato F, Sega FM, Mannella E. Genetic alteration in gastrointestinal cancer: a molecular and cytogenetic study. Anticancer Res. 1993; 13:2325-9.
Search in Google Scholar Back to article
45. Dave BJ, Hopwood VL, Hughes JI, Mellilo D, Jackson GL, Pathak S. Nonrandom chromosomal abnormalities in lymphocyte cultures of individuals with colorectal polyps and of asymptomatic relatives of patients with colorectal cancer or polyps. Int J Radiat Biol. 1995; 68:429-35.
Search in Google Scholar Back to article
46. Sokova OI, Krichenko OP, Kulagina OE, Konstantinova LN, Chebotarev AN, Fleishman EV. Karyotypic anomalies and chromosomal sites of increased fragility in colorectal cancer. Genetika. 1997; 33: 1297-302.
Search in Google Scholar Back to article
47. Rosenblum-Vos LS, Meltzer SJ, Cox JL, Schwartz S. Cytogenetic studies of primary culture of esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 1993; 70:127-31.10.1016/0165-4608(93)90182-L
Open DOI Search in Google Scholar Back to article
48. Calistus Jude AL, Sasikala K, Chandrasekar TS, Ashok Kumar R, Sudha S, Vimala Devi M, et al. Cytogenetic findings in cancerous and non-cancerous lesions of the digestive System. Int J Hum Genet. 2005; 5:199-203.10.1080/09723757.2005.11885926
Search in Google Scholar Back to article
49. Knudtzon J, Svane S. Turner’s syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature. Acta Med Scand. 1988; 223:375-8.10.1111/j.0954-6820.1988.tb15887.x
Search in Google Scholar Back to article
50. Richard F, Muleris M, Dutrillaux B. Chromosome instability in lymphocytes from patients affected by or genetically predisposed to colorectal cancer. Cancer Genet Cytogenet. 1994; 73:23-32.10.1016/0165-4608(94)90178-3
Open DOI Search in Google Scholar Back to article
51. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterol. 2003; 124:521-36.10.1053/gast.2003.5004512557156
Open DOI Search in Google Scholar Back to article
52. Pugazhendhi S, Amte A, Balamurugan R, Subramanian V, Ramakrishna BS. Common NOD2 mutations are absent in patients with Crohn’s disease in India. Indian J Gastroenterol. 2008; 27:201-3.
Search in Google Scholar Back to article
53. Thia KT, Loftus EV, Sandborn WJ and Yang Suk-Kyun. An update on the Epidemiology of Inflammatory Bowel Disease in Asia. Am J Gastroenterol. 2008; 103: 3167-82.10.1111/j.1572-0241.2008.02158.x19086963
Open DOI Search in Google Scholar Back to article
54. Niriella MA, De Silva AP, Dayaratne AH, Ariyasinghe MH, Navarathne MM, Peiris RS, et al. Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey. BMC Gastroenterol. 2010; 10:32-9.10.1186/1471-230X-10-32285652220302651
Open DOI Search in Google Scholar Back to article

DOI: https://doi.org/10.5372/1905-7415.0505.083 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415

Journal RSS Feed

Language: English

Page range: 625 - 633

Published on: Feb 4, 2017

Published by: Chulalongkorn University

In partnership with: Paradigm Publishing Services

Publication frequency: 6 issues per year

Keywords:

Chromosomal aberrations,

NOD2,

Related subjects:

Assistive professions, nursing,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Clinical medicine, other

© 2017 Lakshman Kumar Balasubramanian, Suresh Kuppanan, Balachandar Vellingiri, Sasikala Keshavrao, Venkatakrishnan Leelakrishnan, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 5 (2011): Issue 5 (October 2011)Next article